Painchek Ltd
PCK
Company Profile
Business description
Painchek Ltd is engaged in the development and commercialization of mobile medical device applications that provide pain assessment for individuals who are unable to communicate pain with carers. It operates in one segment, namely the sale of its pain assessment solutions. Its geographic segments include Australia, the United Kingdom, and Other countries, of which it generates the majority of its revenue from Australia.
Contact
35 Lime Street
Suite 401
SydneyNSW2000
AUST: +61 421252123
Sector
Healthcare
Stock type
Defensive
Industry
Health Information Services
Fiscal Year End
30 June 2026
Employees
Stocks News & Analysis
stocks
ASX healthcare giant remains well positioned despite share slump
We welcome the CEO change at CSL but relatively soft plasma performance will postpone recovery
stocks
Australian bank remains overvalued despite strong result
When strong fundamentals meet persistent valuation headwinds.
stocks
Chart of the Week: Soft earnings growth outlook for Australian banks
The latest take from our equity research analysts.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,281.80 | 97.30 | 1.06% |
| CAC 40 | 8,340.56 | 27.32 | 0.33% |
| DAX 40 | 24,852.69 | 3.46 | -0.01% |
| Dow JONES (US) | 49,736.01 | 385.39 | -0.77% |
| FTSE 100 | 10,417.06 | 55.05 | -0.53% |
| HKSE | 27,032.54 | 150.61 | -0.55% |
| NASDAQ | 22,671.63 | 394.83 | -1.71% |
| Nikkei 225 | 57,639.84 | 10.70 | -0.02% |
| NZX 50 Index | 13,531.48 | 85.11 | 0.63% |
| S&P 500 | 6,866.72 | 74.75 | -1.08% |
| S&P/ASX 200 | 9,043.50 | 127.50 | 1.43% |
| SSE Composite Index | 4,134.02 | 2.03 | 0.05% |